ID: ALA594483

Max Phase: Preclinical

Molecular Formula: C16H16N2OS

Molecular Weight: 284.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2sc3ccccc3c2CN)c(N)c1

Standard InChI:  InChI=1S/C16H16N2OS/c1-19-10-6-7-12(14(18)8-10)16-13(9-17)11-4-2-3-5-15(11)20-16/h2-8H,9,17-18H2,1H3

Standard InChI Key:  KQJSJXLNXWWOSG-UHFFFAOYSA-N

Associated Targets(non-human)

Intestinal alkaline phosphatase 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 284.38Molecular Weight (Monoisotopic): 284.0983AlogP: 3.62#Rotatable Bonds: 3
Polar Surface Area: 61.27Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.54CX LogP: 2.63CX LogD: 0.54
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.72Np Likeness Score: -0.68

References

1. Li L, Chang L, Pellet-Rostaing S, Liger F, Lemaire M, Buchet R, Wu Y..  (2009)  Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.,  17  (20): [PMID:19781951] [10.1016/j.bmc.2009.08.048]

Source